Tamara Maes is the founder of Oryzon Genomics SA. Oryzon Genomics SA has raised $35M in total funding. Latest round: IPO. Backed by Najeti fund.
Tamara Maes is a co-founder of Oryzon Genomics SA, a clinical-stage biopharmaceutical company focused on epigenetics for CNS disorders and oncology, founded in 2000 in Barcelona, Spain. Following a capital raise in December 2015, when the company listed on the Madrid Stock Exchange, she controlled 13.15% of outstanding shares.
Full founder directory · Investor directory · Company funding database · Fundraising library